Christopher Joseph Miller, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mental Health Services | 17 | 2022 | 1608 | 3.280 |
Why?
|
United States Department of Veterans Affairs | 23 | 2022 | 870 | 2.850 |
Why?
|
Mohs Surgery | 13 | 2021 | 186 | 2.480 |
Why?
|
Veterans | 16 | 2021 | 2328 | 1.670 |
Why?
|
Skin Neoplasms | 14 | 2022 | 5312 | 1.620 |
Why?
|
MART-1 Antigen | 2 | 2020 | 78 | 1.490 |
Why?
|
Wound Closure Techniques | 2 | 2018 | 82 | 1.330 |
Why?
|
Telemedicine | 9 | 2022 | 2612 | 1.270 |
Why?
|
Evidence-Based Practice | 3 | 2021 | 505 | 1.270 |
Why?
|
Patient Care Team | 10 | 2022 | 2592 | 1.200 |
Why?
|
Bipolar Disorder | 13 | 2020 | 5050 | 1.000 |
Why?
|
Melanoma | 6 | 2020 | 5274 | 0.860 |
Why?
|
Clinical Coding | 2 | 2019 | 175 | 0.770 |
Why?
|
Hyperphosphatemia | 1 | 2018 | 45 | 0.670 |
Why?
|
Facial Neoplasms | 1 | 2018 | 130 | 0.650 |
Why?
|
Mental Health | 10 | 2022 | 2635 | 0.640 |
Why?
|
Rural Health Services | 1 | 2021 | 379 | 0.630 |
Why?
|
Carcinoma, Basal Cell | 2 | 2020 | 522 | 0.620 |
Why?
|
Primary Health Care | 6 | 2021 | 4528 | 0.610 |
Why?
|
Models, Organizational | 4 | 2020 | 587 | 0.600 |
Why?
|
Delivery of Health Care | 6 | 2022 | 4849 | 0.590 |
Why?
|
Melanocytes | 2 | 2018 | 523 | 0.560 |
Why?
|
Interprofessional Relations | 3 | 2018 | 1020 | 0.550 |
Why?
|
Epidermis | 1 | 2018 | 539 | 0.550 |
Why?
|
Health Services Research | 4 | 2020 | 1837 | 0.550 |
Why?
|
Antimanic Agents | 2 | 2016 | 530 | 0.540 |
Why?
|
Antipsychotic Agents | 4 | 2016 | 3067 | 0.540 |
Why?
|
Quality of Health Care | 3 | 2021 | 4281 | 0.540 |
Why?
|
Mental Disorders | 9 | 2020 | 6423 | 0.540 |
Why?
|
Phosphates | 1 | 2018 | 785 | 0.520 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2017 | 275 | 0.500 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1048 | 0.490 |
Why?
|
Behavioral Research | 1 | 2013 | 54 | 0.490 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 8925 | 0.490 |
Why?
|
Surgical Flaps | 3 | 2018 | 1634 | 0.490 |
Why?
|
Computers | 1 | 2016 | 598 | 0.490 |
Why?
|
Qualitative Research | 10 | 2020 | 2535 | 0.480 |
Why?
|
Health Education | 1 | 2020 | 1060 | 0.480 |
Why?
|
Patient Preference | 2 | 2021 | 858 | 0.480 |
Why?
|
Health Services Accessibility | 6 | 2021 | 5010 | 0.460 |
Why?
|
Community Mental Health Centers | 1 | 2012 | 102 | 0.460 |
Why?
|
United States | 33 | 2022 | 67666 | 0.450 |
Why?
|
Shock, Septic | 1 | 2018 | 727 | 0.430 |
Why?
|
Precancerous Conditions | 1 | 2018 | 940 | 0.430 |
Why?
|
Patient Acceptance of Health Care | 3 | 2022 | 2935 | 0.420 |
Why?
|
Antibiotic Prophylaxis | 3 | 2021 | 629 | 0.420 |
Why?
|
Head and Neck Neoplasms | 3 | 2022 | 2741 | 0.380 |
Why?
|
Psychotherapy | 1 | 2019 | 1564 | 0.380 |
Why?
|
Hand | 3 | 2021 | 860 | 0.380 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3701 | 0.370 |
Why?
|
Research Design | 3 | 2020 | 5876 | 0.360 |
Why?
|
Cooperative Behavior | 6 | 2020 | 1562 | 0.360 |
Why?
|
Patient-Centered Care | 2 | 2019 | 1458 | 0.350 |
Why?
|
Neoplasm, Residual | 3 | 2020 | 996 | 0.350 |
Why?
|
Humans | 76 | 2022 | 715118 | 0.340 |
Why?
|
Hutchinson's Melanotic Freckle | 2 | 2018 | 21 | 0.340 |
Why?
|
Long-Term Care | 3 | 2021 | 594 | 0.330 |
Why?
|
Patient Selection | 2 | 2017 | 4320 | 0.310 |
Why?
|
Respiration, Artificial | 1 | 2018 | 2451 | 0.310 |
Why?
|
Health Personnel | 1 | 2020 | 3003 | 0.300 |
Why?
|
Organizational Culture | 2 | 2021 | 527 | 0.300 |
Why?
|
Decision Making | 2 | 2020 | 3828 | 0.290 |
Why?
|
Videoconferencing | 2 | 2020 | 190 | 0.290 |
Why?
|
Stress Disorders, Post-Traumatic | 6 | 2020 | 4074 | 0.280 |
Why?
|
Middle Aged | 37 | 2022 | 214868 | 0.270 |
Why?
|
Aged, 80 and over | 14 | 2022 | 58503 | 0.260 |
Why?
|
Sepsis | 1 | 2018 | 2474 | 0.260 |
Why?
|
Mass Screening | 1 | 2020 | 5204 | 0.250 |
Why?
|
Skin | 1 | 2017 | 4354 | 0.240 |
Why?
|
Vagus Nerve | 2 | 2017 | 447 | 0.240 |
Why?
|
Biomedical Research | 1 | 2019 | 3273 | 0.240 |
Why?
|
Personality | 1 | 2006 | 525 | 0.230 |
Why?
|
Male | 43 | 2022 | 351080 | 0.230 |
Why?
|
Aged | 25 | 2022 | 162672 | 0.230 |
Why?
|
Pandemics | 5 | 2022 | 7212 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9561 | 0.230 |
Why?
|
Chronic Disease | 4 | 2021 | 9022 | 0.220 |
Why?
|
Adult | 33 | 2021 | 212128 | 0.220 |
Why?
|
Female | 44 | 2022 | 377328 | 0.220 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3703 | 0.220 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3894 | 0.220 |
Why?
|
Serotonin | 1 | 2006 | 1037 | 0.220 |
Why?
|
Leg | 2 | 2017 | 1139 | 0.220 |
Why?
|
Ambulatory Care Facilities | 4 | 2021 | 888 | 0.210 |
Why?
|
Surgical Wound Infection | 2 | 2021 | 1502 | 0.210 |
Why?
|
Psychometrics | 3 | 2019 | 2964 | 0.200 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10380 | 0.190 |
Why?
|
Hydroxyl Radical | 1 | 2020 | 77 | 0.190 |
Why?
|
Young Adult | 11 | 2021 | 56155 | 0.190 |
Why?
|
Quality of Life | 5 | 2018 | 11691 | 0.190 |
Why?
|
Cross-Sectional Studies | 8 | 2021 | 23281 | 0.190 |
Why?
|
Oxidants | 1 | 2020 | 166 | 0.180 |
Why?
|
Control Groups | 1 | 2019 | 97 | 0.180 |
Why?
|
Retrospective Studies | 12 | 2022 | 72253 | 0.180 |
Why?
|
Postoperative Complications | 2 | 2018 | 15097 | 0.180 |
Why?
|
Scalp | 1 | 2022 | 377 | 0.180 |
Why?
|
Self Report | 3 | 2019 | 3420 | 0.180 |
Why?
|
Biopsy | 4 | 2019 | 6750 | 0.180 |
Why?
|
Forehead | 1 | 2018 | 75 | 0.180 |
Why?
|
Frontal Bone | 1 | 2018 | 108 | 0.170 |
Why?
|
Organizational Policy | 1 | 2021 | 439 | 0.170 |
Why?
|
Periosteum | 1 | 2018 | 140 | 0.170 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 129 | 0.170 |
Why?
|
Adolescent | 11 | 2021 | 85001 | 0.170 |
Why?
|
Program Evaluation | 4 | 2021 | 2529 | 0.170 |
Why?
|
Free Tissue Flaps | 1 | 2022 | 290 | 0.170 |
Why?
|
Mentally Ill Persons | 1 | 2018 | 126 | 0.170 |
Why?
|
Decision Trees | 1 | 2020 | 523 | 0.170 |
Why?
|
Empirical Research | 1 | 2018 | 116 | 0.160 |
Why?
|
Social Isolation | 1 | 2020 | 334 | 0.160 |
Why?
|
Outpatients | 2 | 2022 | 1366 | 0.160 |
Why?
|
Genitalia | 1 | 2017 | 101 | 0.160 |
Why?
|
Telecommunications | 1 | 2017 | 84 | 0.160 |
Why?
|
Immunocompetence | 1 | 2017 | 149 | 0.150 |
Why?
|
Hospitals, Veterans | 1 | 2019 | 406 | 0.150 |
Why?
|
Health Facilities | 1 | 2021 | 458 | 0.150 |
Why?
|
Duodenum | 1 | 2019 | 473 | 0.150 |
Why?
|
Autonomic Nerve Block | 1 | 2017 | 76 | 0.150 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2587 | 0.150 |
Why?
|
Obesity, Morbid | 2 | 2017 | 1082 | 0.150 |
Why?
|
Toes | 1 | 2017 | 196 | 0.150 |
Why?
|
Professional Role | 1 | 2019 | 304 | 0.150 |
Why?
|
Depression | 4 | 2019 | 7256 | 0.140 |
Why?
|
Skin Transplantation | 2 | 2018 | 1123 | 0.140 |
Why?
|
Medication Therapy Management | 1 | 2016 | 129 | 0.140 |
Why?
|
Foot Diseases | 1 | 2017 | 145 | 0.140 |
Why?
|
Health Services | 1 | 2020 | 734 | 0.140 |
Why?
|
Perception | 2 | 2019 | 1179 | 0.140 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 430 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1529 | 0.130 |
Why?
|
Tendons | 1 | 2018 | 505 | 0.130 |
Why?
|
Rectum | 1 | 2019 | 887 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1660 | 0.130 |
Why?
|
Waiting Lists | 1 | 2019 | 713 | 0.130 |
Why?
|
Vagus Nerve Stimulation | 1 | 2017 | 183 | 0.130 |
Why?
|
Hospitalization | 4 | 2021 | 9718 | 0.130 |
Why?
|
Personal Satisfaction | 1 | 2018 | 594 | 0.130 |
Why?
|
Physicians, Primary Care | 2 | 2017 | 572 | 0.120 |
Why?
|
Dermatofibrosarcoma | 1 | 2014 | 60 | 0.120 |
Why?
|
Foot | 1 | 2017 | 510 | 0.120 |
Why?
|
Fingers | 1 | 2017 | 522 | 0.120 |
Why?
|
Community Mental Health Services | 2 | 2013 | 400 | 0.120 |
Why?
|
Extremities | 1 | 2018 | 882 | 0.120 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11191 | 0.120 |
Why?
|
Reminder Systems | 1 | 2016 | 388 | 0.110 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 801 | 0.110 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 683 | 0.110 |
Why?
|
Hair Follicle | 1 | 2014 | 221 | 0.110 |
Why?
|
Clinical Competence | 2 | 2019 | 4646 | 0.110 |
Why?
|
Organ Specificity | 1 | 2017 | 2049 | 0.110 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 363 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5980 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2019 | 6198 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1273 | 0.100 |
Why?
|
Women's Health | 1 | 2020 | 1934 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1464 | 0.100 |
Why?
|
Electric Stimulation Therapy | 1 | 2017 | 624 | 0.100 |
Why?
|
Metered Dose Inhalers | 1 | 2010 | 24 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1671 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 2003 | 0.100 |
Why?
|
Ethanolamines | 1 | 2010 | 152 | 0.090 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2022 | 2126 | 0.090 |
Why?
|
Budesonide | 1 | 2010 | 155 | 0.090 |
Why?
|
Nerve Block | 1 | 2015 | 638 | 0.090 |
Why?
|
Risk Factors | 8 | 2021 | 70705 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2021 | 3562 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2038 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7480 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6538 | 0.080 |
Why?
|
Time Factors | 3 | 2021 | 41082 | 0.080 |
Why?
|
Alcoholism | 1 | 2018 | 1855 | 0.080 |
Why?
|
Weight Loss | 2 | 2017 | 2487 | 0.080 |
Why?
|
Arthritis | 1 | 2012 | 650 | 0.080 |
Why?
|
Health Care Costs | 1 | 2020 | 3171 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2021 | 4230 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2016 | 1979 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39285 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2021 | 62186 | 0.070 |
Why?
|
Bronchodilator Agents | 1 | 2010 | 510 | 0.070 |
Why?
|
Reward | 1 | 2012 | 856 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11766 | 0.070 |
Why?
|
Receptors, Serotonin | 1 | 2006 | 208 | 0.070 |
Why?
|
Harm Reduction | 1 | 2006 | 114 | 0.070 |
Why?
|
Emotions | 2 | 2018 | 2441 | 0.070 |
Why?
|
Organizational Innovation | 2 | 2020 | 572 | 0.070 |
Why?
|
Critical Illness | 1 | 2018 | 2531 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4028 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2018 | 3441 | 0.070 |
Why?
|
Temperament | 1 | 2006 | 279 | 0.060 |
Why?
|
Impulsive Behavior | 1 | 2006 | 305 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 1434 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2944 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18789 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6480 | 0.060 |
Why?
|
Personality Inventory | 1 | 2006 | 1055 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3078 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8016 | 0.060 |
Why?
|
Cost of Illness | 1 | 2012 | 1840 | 0.060 |
Why?
|
Survival Rate | 1 | 2017 | 13255 | 0.060 |
Why?
|
Health Surveys | 1 | 2012 | 4021 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3158 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3276 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2022 | 287 | 0.050 |
Why?
|
Metacarpal Bones | 1 | 2021 | 72 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2018 | 4465 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2019 | 113 | 0.050 |
Why?
|
Ferrous Compounds | 1 | 2020 | 44 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2014 | 16011 | 0.040 |
Why?
|
Quality Improvement | 3 | 2019 | 3748 | 0.040 |
Why?
|
Geography | 1 | 2020 | 690 | 0.040 |
Why?
|
Space-Time Clustering | 1 | 2016 | 61 | 0.040 |
Why?
|
Blood | 1 | 2019 | 618 | 0.040 |
Why?
|
Stereotyping | 1 | 2018 | 239 | 0.040 |
Why?
|
Specialties, Surgical | 1 | 2021 | 385 | 0.040 |
Why?
|
Internship and Residency | 1 | 2016 | 5618 | 0.040 |
Why?
|
Arteries | 1 | 2021 | 1106 | 0.040 |
Why?
|
Patient Satisfaction | 2 | 2020 | 3396 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2017 | 11900 | 0.040 |
Why?
|
Schizophrenia | 1 | 2014 | 6741 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 995 | 0.040 |
Why?
|
Financing, Personal | 1 | 2018 | 313 | 0.040 |
Why?
|
Heartburn | 1 | 2015 | 65 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2973 | 0.030 |
Why?
|
Dyspepsia | 1 | 2015 | 92 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1900 | 0.030 |
Why?
|
Demography | 1 | 2019 | 1621 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2334 | 0.030 |
Why?
|
Community Health Services | 1 | 2019 | 658 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 15616 | 0.030 |
Why?
|
Valproic Acid | 1 | 2016 | 447 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 810 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3963 | 0.030 |
Why?
|
Lithium | 1 | 2016 | 615 | 0.030 |
Why?
|
Behavioral Medicine | 1 | 2013 | 49 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2509 | 0.030 |
Why?
|
Electrodes | 1 | 2015 | 597 | 0.030 |
Why?
|
Feedback | 1 | 2016 | 754 | 0.030 |
Why?
|
Trust | 1 | 2017 | 485 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1330 | 0.030 |
Why?
|
Anxiety | 1 | 2006 | 3898 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1243 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2019 | 2595 | 0.030 |
Why?
|
Social Behavior | 1 | 2018 | 1111 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2004 | 0.030 |
Why?
|
Iron | 1 | 2020 | 1735 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2018 | 2746 | 0.030 |
Why?
|
Asthma | 1 | 2010 | 5909 | 0.030 |
Why?
|
Prevalence | 2 | 2020 | 14869 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1875 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 820 | 0.020 |
Why?
|
Military Personnel | 1 | 2018 | 1060 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3769 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2015 | 1028 | 0.020 |
Why?
|
Counseling | 1 | 2016 | 1505 | 0.020 |
Why?
|
Teaching | 1 | 2016 | 1189 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3062 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 21789 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5898 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2773 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10531 | 0.020 |
Why?
|
Leadership | 1 | 2017 | 1342 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2381 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1722 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2010 | 1104 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4376 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2600 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10651 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 39804 | 0.020 |
Why?
|
Anti-Asthmatic Agents | 1 | 2010 | 546 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1832 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1671 | 0.020 |
Why?
|
Psychiatry | 1 | 2016 | 1615 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2836 | 0.020 |
Why?
|
Curriculum | 1 | 2016 | 3398 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3498 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7722 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 5039 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19497 | 0.010 |
Why?
|
Brain | 1 | 2006 | 25188 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10423 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12488 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 51182 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23510 | 0.010 |
Why?
|